Navigation Links
Patents Issued Covering Stable Tablet Formulation and Once Daily Dosing Regimen for Kuvan
Date:7/30/2009

ed patients in the developed world, is caused by a deficiency of the enzyme phenylalanine hydroxylase. PAH is required for the metabolism of phenylalanine, an essential amino acid found in most protein-containing foods. If the active enzyme is not present in sufficient quantities, Phe accumulates to abnormally high levels in the blood and becomes toxic to the brain, resulting in a variety of complications including severe mental retardation and brain damage, mental illness, seizures, tremors, and limited cognitive ability. As a result of newborn screening efforts implemented in the 1960s and early 1970s, virtually all PKU patients under the age of 40 in developed countries have been diagnosed at birth. To learn more about PKU, please visit www.PKU.com. Information on this website is not incorporated by reference into this press release.

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme(R)( )(galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R)( )(sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in development for the treatment of PKU and GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase I/II clinical development for the treatment of MPS IVA. For additional information, please visit www.B
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. 90 Brain Fitness Patents for Posit Science
2. Misonix Announces the Purchase of Patents From ProRhythm, Inc.
3. Orexigen(R) Therapeutics Announces In-Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave(R)
4. Impliant Granted Two New U.S. Patents and Successfully Defends European Patent Opposition Case
5. CAP Joins Landmark Lawsuit Challenging Legality of Myriad Genetics Gene Patents
6. ACMG Joins Lawsuit Challenging Patents on Breast Cancer Genes; Genes Are Naturally Occurring Substances and Should Not Be Patented, Says American College of Medical Genetics
7. ACLU Challenges Patents on Breast Cancer Genes
8. MMR Information Systems, Inc. Announces 250,000 Membership Milestone and Granting of International Patents
9. German Federal Patent Court Invalidates Wake Forest NPWT Patents Licensed to KCI
10. United States Patent Office Rejects KCIs Patents
11. ALSIUS CORPORATION PREPARED TO INVALIDATE ZOLL TEMPERATURE MANAGEMENT PATENTS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... has opened press registration for TU-Automotive Detroit as the ... headlines of major publications world-wide. With 150+ speakers from ... to share their visions for the future of connected ... to go behind the scenes and hear major automakers’ ... year we’re releasing a preview of all the major ...
(Date:5/6/2015)... Water NSW (New South ... manage and distribute imagery, LiDAR, and Elevation Data within ... driest continents on earth, and the need to ensure ... erratic seasonal rainfalls has driven the development of several ... manages raw water supplies for NSW, including high quality ...
(Date:5/6/2015)... May 06, 2015 Cloud security companies ... announced a strategic partnership to help small-to-medium businesses secure ... two industry-leading companies are teaming up to transition SafeMonk ... , “We’re thrilled to welcome SafeMonk users to the ... the people behind SafeMonk, the global powerhouse SafeNet (now ...
(Date:5/6/2015)... 2015 National Physical Fitness and Sports ... within the U.S. Department of Health and Human Services ... Fitness and Sports Month. It is dedicated to ... to health. Throughout the month of May, Americans ... fit. , The HHS details the benefits of regular ...
(Date:5/6/2015)... 2015 Most people in the United States ... other care after age 65. But less than half of ... or even talking about it, reports the May 2015 ... two problems. One is losing control over the care they'll ... Dr. David Grabowski, a professor of health care policy at ...
Breaking Medicine News(10 mins):Health News:Press Registration for TU-Automotive Detroit Now Open 2Health News:Water NSW Unlocks Imagery and Elevation Data Archive Across the Enterprise using Hexagon Geospatial Solutions 2Health News:Water NSW Unlocks Imagery and Elevation Data Archive Across the Enterprise using Hexagon Geospatial Solutions 3Health News:Sookasa Grows Globally With SafeMonk Partnership 2Health News:Sookasa Grows Globally With SafeMonk Partnership 3Health News:Narconon Arrowhead Issues Guide for Physical Fitness and Sports Month 2Health News:Narconon Arrowhead Issues Guide for Physical Fitness and Sports Month 3Health News:Start Planning Now for Long-Term Care, from the May 2015 Harvard Health Letter 2
... concern over discrepancies in official data for key sectors ... called for a revamp of the national statistical system ... the administrative set up and traditional records, the (statistical) ... changing times," Manmohan Singh said in his address at ...
... the Institute Pasteur has recently shown that the tuberculosis ... fat cells. //This formidable pathogen is protected against even ... it may remain dormant for years. ,This ... possible strategies for fighting tuberculosis. Attempts to eradicate the ...
... research centre is being planned at the Pune-based ... diseases//, a general says. ,"Stem cell therapy ... will be the futuristic treatment replacing drug therapy ... diabetes, Parkinson's disease, epilepsy, multiple sclerosis, eye and ...
... San Diego biologists have shown that the chemical language ... electrical activity in the developing nervous system. The findings ... as a treatment for a wide range of brain ... the early on-line edition of the journal Proceedings of ...
... Christmas is indeed a ‘ubiquitous’ festival, as it is celebrated ... an estimated 26 million Indian homes.// The joys of the ... are seen making the most of the special bargains and ... time for the celebration. Plans are afoot in great enthusiasm ...
... director of Clarkson's Center for Air Resources Engineering ... on airborne pollution who serves on the Environmental ... also one of scores of health officials and ... the casual link between pollutants and respiratory illnesses. ...
Cached Medicine News:Health News:Manmohan Calls for Statistical Reforms in Healthcare and Education 2Health News:Tuberculosis: The Bacillus Takes Refuge in Adipose Cells 2Health News:Military College to Set Up Stem Cell Research Centre 2Health News:Electrical Activity Alters Language Used By Nerve Cells 2Health News:Electrical Activity Alters Language Used By Nerve Cells 3Health News:Come Apart and Rest Awhile – It’s Christma 2Health News:Come Apart and Rest Awhile – It’s Christma 3Health News:Research on to Find Link Between Airborne Pollutants and Respiratory Illness 2
(Date:5/6/2015)... BOSTON, May 6, 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: ... financial results for the three-month period ended March 31, ... were $8.3 million, an increase of 19% as compared ... , Product revenues increased 41% year-over-year, enabled by ... shipments to Merck Serono in the fourth quarter of ...
(Date:5/6/2015)... 6, 2015 First ... dolutegravir and rilpivirine   ViiV ... III clinical trial programme to evaluate the safety ... [1] ) as maintenance therapy for adult patients ... replicate studies evaluating 48 week viral suppression with ...
(Date:5/6/2015)... 2015 Woodford Patient Capital ... Trust and the Bill & Melinda Gates Foundation ... a leading monoclonal antibody biopharmaceutical company, announced today ... million to complete a US$90 million Series B ... Woodford Patient Capital Trust plc (LSE:WPCT,"Woodford") and Malin ...
Breaking Medicine Technology:Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 2Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 3Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 4Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 5Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 6Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 7Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 8Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 9Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 10Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 11ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 2ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 3ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 4ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 5ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 6ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 7ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 8ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 9ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 10Kymab Secures US$90 Million Funding 2Kymab Secures US$90 Million Funding 3Kymab Secures US$90 Million Funding 4
This extended 10 ul combats contamination by keeping your pipettor out of 1.5 ul and 2.0 ul tubes. Utilizes MicroPoint design and 2 ul reference mark....
This 10 L tip was designed for the Pipetman P-2 and P-10. Its MicroPoint design and 2 L reference mark make it ideal for low volume pipetting....
... Processor is a primary component of an ... processing, sampling, and slide preparation all ... MonoPrep LBP Processor produces high-quality sample slides ... range of cytology specimen types. It processes ...
... Binding, Graduated Pipet Tips - 2l - 200l. ... referenced. Produced & packaged completely by automation. RNAse ... packaged 96 tips/rack and 10 racks/cs. AVR2 is ... racks/cs. AVR3 is the Stacked Rack packaged 96 ...
Medicine Products: